The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer

Institute Of Fundamental Physics Sejong University

Department Of Oral Pathology School Of Dentistry Chonbuk National University

Department Of Chemistry The Catholic University Of Korea

Department Of Pathology College Of Medicine Hanyang University

Department Of Pathology College Of Medicine Hanyang University

Division Of Basic And Applied Science Korea National Cancer Cencer

Drug Discovery Division Center For Drug Discovery Technologies Korea Research Institute Of Chemical

Department of Pathology College of Medicine, Hanyang University

Department of Pathology College of Medicine, Hanyang University

Department of Pathology College of Medicine, Hanyang University

Department of Pathology College of Medicine, Hanyang University

Institute For Bioengineering And Biopharmaceutical Research (ibbr) Hanyang University

Department Of Pathology College Of Medicine Hanyang University

Department Of Pathology College Of Medicine Hanyang University

Department Of Pathology College Of Medicine Hanyang University

Department Of Oral Pathology School Of Dentistry And Institute Of Oral Bioscience Brain Korea 21 Pro

Department Of Oral Pathology School Of Dentistry Institute Of Oral Bioscience Chonbuk National Unive

Department Of Pathology College Of Medicine Hanyang University